INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo ALSAN

SCHEDULING STATUS:
S2

PROPRIETARY NAME
(and dosage form):

ALSAN

COMPOSITION:
Each 100 g of cream contains:
Mepyramine Maleate        2 g
Preservatives:
  Methylhydroxybenzoate 0,16% m/m
  Propylhydroxybenzoate 0,02% m/m
Contains no TARTRAZINE.
Contains Sodium metabisulphite 0,1% m/m

PHARMACOLOGICAL CLASSIFICATION:
A 13.4 Antipruritics (relieving itching)

PHARMACOLOGICAL ACTION:
Histamine H1 receptor antagonists compete reversibly with histamine for H1 receptor sites on effector cells. They suppress those symptoms due to histamine release.
ALSAN has the actions and uses of antihistamine (medicine used to prevent or relieve symptoms of some types of allergies) drugs.

INDICATIONS:
ALSAN
is employed locally for allergic (unusual sensitisation) and pruritic (itching) skin disorders or for the symptomatic relief of hypersensitivity reactions. It is also employed locally for insect bites or stings.

CONTRA-INDICATIONS:
Hypersensitivity to any of the ingredients. Cross sensitivity to other antihistamines.
Pregnancy –Safety in pregnancy has not been established.
ALSAN should not be used for acute vesicular (severe blister) and exudative dermatoses (fluid eruptions from skin).

DOSAGE AND DIRECTIONS FOR USE:
Apply to affected area two to three times a day.

SIDE EFFECTS AND SPECIAL PRECAUTIONS:
Local application of ALSAN carries a risk of sensitisation but dermatitis (inflammation of the skin) may also result.

KNOWN SYMPTOMS OF OVER DOSAGE AND PARTICULARS OF ITS TREATMENT:
For external use only

IDENTIFICATION:
Pale green cream with a pleasant aromatic odour

PRESENTATION:
25 g tubes and 500 g white or amber ointment jars.

STORAGE INSTRUCTIONS:
Store in a cool place, below 25ºC.
KEEP OUT OF REACH OF CHILDREN

REGISTRATION NUMBER:
G 1881 (Act 101/1965)

NAME AND BUSINESS ADDRESS OF THE APPLICANT:
Gulf Drug Company (PTY) LTD.
22 Burnside Drive
Old Mill Industrial Park
Mount Edgecombe
4300

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
March 1973

New addition to this site: July 2010
Source: Pharmaceutical Industry

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2010